Chinese Province Quickly Becoming the Next Major Hub for Overseas Biopharmaceutical and High Tech Development

SAN DIEGO and SAN FRANCISCO, Oct. 2, 2014 /PRNewswire/ -- Pharmaceutical and medical equipment companies are expected to nearly triple their spending in China from $357 billion in 2011, to $1 trillion by 2020, according to McKinsey Consulting. Comparatively, China's global high tech manufacturing output has risen to 24% over the last 15 years, second only to the US, according to the National Science Board. With increasing interest in China from the life science and high tech industries, Zhongshan may be exactly what many companies are looking for. As the Hi-Tech Development Zone of Zhongshan opens its doors to United States investment, its Government Officials and Corporate Leadership have planned speaking engagements in San Diego and San Francisco the first week of November, 2014. These summits will discuss the benefits and successes of R&D, manufacturing and business development in Zhongshan, including:

• Current drug development/hi-tech industry trends in China
• Capabilities of the specialized Bio and High Tech Parks
• Zhongshan's Competitive Edge
• Compelling Case Studies

To view the multimedia assets associated with this release, please click http://www.multivu.com/players/English/7326851-hi-tech-development-zone-of-zhongshan-china-hosts-summits-biopharma-in-u-s/ 

The summits, and its webinar component, are free and open to any company or organization, in the related industries, with an interest in business development in China. Click here to RSVP and for further information. 

Zhongshan is one of the earliest development zones in Southern China. Since 1991, they have built high quality Bio and High Tech Parks; support from regulatory agencies, such as the CFDA; strong connections with global and national trade organizations, and the infrastructure necessary for successful R&D and manufacturing. What they don't have is the congestion, poor air quality and higher land prices that are common to cities like Beijing.

"China has become one of the top choices for global pharmaceutical R&D, and high tech manufacturing. Zhongshan's timing is optimal in helping companies capitalize on this trend." Says Baron Suen, VP of American Zhongshan Association of Commerce. "For companies looking to break into the China market or to expand their existing overseas business, this is an ideal opportunity."

Please visit www.zshitech.com for more information about the Hi-Tech Development Zone of Zhongshan, China.

To view the multimedia assets associated with this release, please click http://www.multivu.com/players/English/7326851-hi-tech-development-zone-of-zhongshan-china-hosts-summits-biopharma-in-u-s/

SOURCE Hi-Tech Development Zone of Zhongshan, China